Maternal serum hormonal factors in the pathogenesis of preeclampsia

Obstetrical and Gynecological Survey

Volumn 68, Issue 2, 2013, Pages 141-150

  Salustiano, Eugênia Maria Assuncão ^a,b   De Pinho, Joao Correia ^b   Provost, Karli ^b   Ruano, Rodrigo ^a   Zugaib, Marcelo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGININE; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HYDROCORTISONE; MELATONIN; NORADRENALIN; TRYPTOPHAN; VASOPRESSIN;

ADRENAL CORTEX; CIRCADIAN RHYTHM; HORMONE SYNTHESIS; HYDROCORTISONE RELEASE; MATERNAL SERUM; PATHOGENESIS; PINEAL BODY; PREECLAMPSIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TROPHOBLAST;

BIOLOGICAL MARKERS; FEMALE; HORMONES; HUMANS; MATERNAL SERUM SCREENING TESTS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84874390225     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31827f2500     Document Type: Review

References (71)

1. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia [published online ahead of print June 8, 2007]. Microvasc Res. 2008;75:1-8.
2. Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 2001;34:1227-35. Published online ahead of print 2001/10/11.
3. Vega CE, Kahhale S, Zugaib M. Maternal mortality due to arterial hypertension in Sao Paulo City (1995-1999). Clinics (Sao Paulo). 2007;62:679-84. Published online ahead of print 2008/01/23.
4. Harris LK. Review: trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta. 2010; 31(suppl):S93YS98. Published online ahead of print 2010/01/12.
5. Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16:510-24. Published online ahead of print 2010/04/15.
6. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63:534-43. Published online ahead of print 2010/03/25.
7. Nakamura Y, Tamura H, Kashida S, et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001;30:29-33. Published online ahead of print 2001/02/13.
8. Ho JT, Lewis JG, O'Loughlin P, et al. Reduced maternal corticosteroid-binding globulin and cortisol levels in preeclampsia and gamete recipient pregnancies. Clin Endocrinol. 2007;66:869-77. Published online ahead of print 2007/04/18.
9. Ma RQ, Sun MN, Yang Z. Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model. Chin Med J. 2010;123:707-12. Published online ahead of print 2010/04/07.
10. Escher G, Mohaupt M. Role of aldosterone availability in preeclampsia. Mol Aspects Med. 2007;28:245-54. Published online ahead of print 2007/05/22.
11. Anton L, Brosnihan KB. Systemic and uteroplacental reninY angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis. 2008;2:349-62. Published online ahead of print 2009/01/07.
12. Axelrold J. Pineal gland: a neurochemical transducer. Science. 1974;184:1341-1348.
13. Kappers JA. The development, topographical relations and innervation of the epiphysis cerebri in the albino rat. Z Zellforsch Mikrosk Anat. 1960;52:163-215. Published online ahead of print 1960/01/01.
14. Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 2004;25:177-95. Published online ahead of print 2004/12/14.
15. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418:935-41. Published online ahead of print 2002/08/29.
16. Hardeland R, Poeggeler B, Niebergall R, et al. Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res. 2003;34: 17-25. Published online ahead of print 2002/12/18.
17. Hardeland R, Pandi-Perumal SR, Cardinali DP. Melatonin. Int J Biochem Cell Biol. 2006;38:313-6. Published online ahead of print 2005/10/13.
18. Axelrod J, Weissbach H. Enzymatic O-methylation of N-acetylserotonin tomelatonin. Science. 1960;131:1312. Published online ahead of print 1960/04/29.
19. Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 2003;55:325-95. Published online ahead of print 2003/05/30.
20. Nowak JZ, Zawilska JB. Melatonin and its physiological and therapeutic properties. Pharm World Sci. 1998;20:18-27. Published online ahead of print 1998/04/16.
21. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005;27:189-200. Published online ahead of print 2005/10/12.
22. Couto-Moraes R, Palermo-Neto J, Markus RP. The immunepineal axis: stress as a modulator of pineal gland function. Ann N Y Acad Sci. 2009;1153:193-202. Published online ahead of print 2009/02/25.
23. Markus RP, Franco DG, Carvalho LA, et al. Acute increase in urinary 6-sulfatoximelatonin after clomipramine, as a predictive measure for emotional improvement. J Psychopharmacol. 2010;24:855-60. Published online ahead of print 2009/03/07.
24. Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res. 2010;181:127-51. Published online ahead of print 2010/05/19.
25. Hardeland R, Cardinali DP, Srinivasan V, et al. MelatoninVa pleiotropic, orchestrating regulator molecule. Prog Neurobiol. 2011;93:350-84. Published online ahead of print 2011/01/05.
26. Kivela A. Serum melatonin during human pregnancy. Acta Endocrinol. 1991;124:233-7. Published online ahead of print 1991/03/01.
27. Tamura H, Nakamura Y, Terron MP, et al. Melatonin and pregnancy in the human. Reprod Toxicol. 2008;25:291-303. Published online ahead of print 2008/05/20.
28. Tranquilli AL, Turi A, Giannubilo SR, et al. Circadian melatonin concentration rhythm is lost in pregnant women with altered blood pressure rhythm. Gynecol Endocrinol. 2004;18:124-9. Published online ahead of print 2004/07/17.
29. Guyton AC, Hall JE. Textbook ofmedical physiology.Philadelphia, PA: Saunders, Elsevier.
30. Vianna P, BauerME, Dornfeld D, et al. Distress conditions during pregnancy may lead to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to glucocorticoids. Med Hypotheses. 2011;77:188-91. Published online ahead of print 2011/05/10.
31. Allolio B, Hoffmann J, Linton EA, et al. Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol. 1990;33:279-89. Published online ahead of print 1990/08/01.
32. Bindoli A, Rigobello MP, Deeble DJ. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic BiolMed. 1992;13:391-405. Published online ahead of print 1992/10/01.
33. Ohtsuka A, Kojima H, Ohtani T, et al. Vitamin E reduces glucocorticoid-induced oxidative stress in rat skeletal muscle. J Nutr Sci Vitaminol. 1998;44:779-86. Published online ahead of print 1999/04/10.
34. Sikkema JM, Robles de Medina PG, Schaad RR, et al. Salivary cortisol levels and anxiety are not increased in women destined to develop preeclampsia. J Psychosom Res. 2001;50:45-9. Published online ahead of print 2001/03/22.
35. Irani RA, Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta. 2008;29: 763-71. Published online ahead of print 2008/08/09.
36. Oats JN, Broughton Pipkin F, Symonds EM, et al. A prospective study of plasma angiotensin-converting enzyme in normotensive primigravidae and their infants. Br J Obstet Gynaecol. 1981;88:1204-10. Published online ahead of print 1981/12/01.
37. Pedersen EB, Christensen NJ, Christensen P, et al. Prostaglandins, renin, aldosterone, and catecholamines in preeclampsia. Acta Med Scand Suppl. 1983;677:40-3. Published online ahead of print 1983/01/01.
38. Pedersen EB, Christensen NJ, Christensen P, et al. Prostaglandins, catecholamines, renin and aldosterone during hypertensive and normotensive pregnancy. Clin Exp Hypertens A Theory Pract. 1982;4:1453-67. Published online ahead of print 1982/01/01.
39. Shojaati K, Causevic M, Kadereit B, et al. Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int. 2004;66:2322-8. Published online ahead of print 2004/12/01.
40. Krege JH, Katz VL. A proposed relationship between vasopressinase altered vasopressin and preeclampsia. Med Hypotheses. 1990;31:283-7. Published online ahead of print 1990/04/01.
41. Oian P, Kjeldsen SE, Eide I, et al. Adrenaline and preeclampsia. Acta Med Scand Suppl. 1985;693:29-32. Published online ahead of print 1985/01/01.
42. Oian P, Kjeldsen SE, Eide IK. PreeclampsiaVa state of sympathetic overactivity. N Engl J Med. 1997;336:1326-7; author reply 7. Published online ahead of print 1997/05/01.
43. Oian P, Kjeldsen SE, Eide I, et al. Increased arterial catecholamines in pre-eclampsia. Acta Obstet Gynecol Scand. 1986;65:613-7. Published online ahead of print 1986/01/01.
44. Kaaja RJ, Moore MP, Yandle TG, et al. Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens Pregnancy. 1999;18:173-87. Published online ahead of print 1999/09/07.
45. Furuhashi N, Tsujiei M, Kimura H, et al. Plasma renin activity, angiotensin II, prostacyclin and thromboxane A2 concentrations in 139 preeclamptic patients. Tohoku J Exp Med. 1990;162: 235-41. Published online ahead of print 1990/11/01.
46. Minegishi T, Nakamura M, Abe K, et al. Adrenomedullin and atrial natriuretic peptide concentrations in normal pregnancy and pre-eclampsia. Mol Hum Reprod. 1999;5:767-70. Published online ahead of print 1999/07/28.
47. Furuhashi N, Tsujiei M, Kimura H, et al. Maternal and fetal atrial natriuretic peptide levels, maternal plasma renin activity, angiotensin II, prostacyclin and thromboxane A2 levels in normal and preeclamptic pregnancies. Tohoku J Exp Med. 1991;165:79-86. Published online ahead of print 1991/10/01.
48. Davidson NC, Coutie WJ, Struthers AD. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro. Circulation. 1995;91: 1276-7. Published online ahead of print 1995/02/15.
49. Davidson NC, Struthers AD. Brain natriuretic peptide. J Hypertens.1994;12:329-36. Published online ahead of print 1994/04/01.
50. Resnik JL, Hong C, Resnik R, et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005;193:450-4. Published online ahead of print 2005/08/16.
51. Itoh H, Sagawa N, Mori T, Mukoyama M, Nakao K, Imura H. Plasma brain natriuretic peptide level in pregnant women with pregnancy-induced hypertension. Obstet Gynecol. 1993;82:71-7. Published online ahead of print 1993/07/01.
52. Khatun S, Kanayama N, Belayet HM, et al. Induction of preeclampsia like phenomena by stimulation of sympathetic nerve with cold and fasting stress. Eur J Obstet Gynecol Reprod Biol. 1999;86:89-97. Published online ahead of print 1999/09/02.
53. Xia Y, Kellems RE. Receptor-activating autoantibodies and disease: preeclampsia and beyond. Exp Rev Clin Immunol. 2011;7:659-74. Published online ahead of print 2011/09/08.
54. Wenzel K, Rajakumar A, Haase H, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77-84. Published online ahead of print 2011/05/18.
55. Pulgar VM, Yamashiro H, Rose JC, et al. Role of the AT2 receptor in modulating the angiotensin II contractile response of the uterine artery at mid-gestation. JRAAS. 2011;12: 176-83. Published online ahead of print 2011/03/23.
56. Mishra N, Nugent WH, Mahavadi S, et al. Mechanisms of enhanced vascular reactivity in preeclampsia. Hypertension. 2011;58:867-73. Published online ahead of print 2011/09/29.
57. Irani RA, Xia Y. Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol. 2011;31:47-58. Published online ahead of print 2011/01/27.
58. Saxena AR, Karumanchi SA, Brown NJ, et al. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010;55:1239-45. Published online ahead of print 2010/03/24.
59. Brosnihan KB, Hering L, Dechend R, et al. Increased angiotensin II in the mesometrial triangle of a transgenic rat model of preeclampsia. Hypertension. 2010;55:562-6. Published online ahead of print 2009/12/30.
60. Knofler M, Pollheimer J. IFPA Award in Placentology lecture: molecular regulation of human trophoblast invasion. Placenta. 2012;33(suppl):S55YS62. Published online ahead of print 2011/10/25.
61. Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol. 2010; 54:269-80. Published online ahead of print 2009/10/31.
62. Hoffmann P, Feige JJ, Alfaidy N. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta. 2007;28: 1049-58. Published online ahead of print 2007/05/29.
63. Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol. 2006; 101:1252-61. Published online ahead of print 2006/06/24.
64. Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology. 2006;147: 1675-84. Published online ahead of print 2005/12/31.
65. Al Kadi H, Nasrat H, Broughton Pipkin F. A prospective, longitudinal study of the renin-angiotensin system, prostacyclin and thromboxane in the first trimester of normal human pregnancy: association with birthweight. Hum Reprod. 2005; 20:3157-62. Published online ahead of print 2005/07/12.
66. Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol. 1999;23:45-57. Published online ahead of print 1999/04/02.
67. Gennari-Moser C, Khankin EV, Schuller S, et al. Regulation of placental growth by aldosterone and cortisol. Endocrinology. 2011;152:263-71. Published online ahead of print 2010/11/12.
68. Milczarek R, Hallmann A, Sokolowska E, et al. Melatonin enhances antioxidant action of alpha-tocopherol and ascorbate against NADPH-and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res. 2010;49:149-55. Published online ahead of print 2010/06/08.
69. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin and reproduction revisited. Biol Reprod. 2009;81:445-56. Published online ahead of print 2009/05/15.
70. Okatani Y, Wakatsuki A, Shinohara K, et al. Melatonin protects against oxidative mitochondrial damage induced in rat placenta by ischemia and reperfusion. J Pineal Res. 2001;31:173-8. Published online ahead of print 2001/09/14.
71. Okatani Y, Wakatsuki A, Watanabe K, et al. Melatonin inhibits vasospastic action of oxidized low-density lipoprotein in human umbilical arteries. J PinealRes. 2000;29:74-80. Published online ahead of print 2000/09/12.